Home > Boards > US Listed > Biotechs > Halozyme Therapeutics (HALO)

It sounds like they know that PEGpH20 is

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Fred Kadiddlehopper Member Profile
 
Followed By 23
Posts 3,400
Boards Moderated 1
Alias Born 09/22/06
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2019 1:41:16 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 6/7/2019 5:11:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 4:45:58 PM
Halozyme To Participate In Upcoming Investor Conferences PR Newswire (US) - 6/4/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 5:24:28 PM
Halozyme Announces argenx Has Selected Second Target Under ENHANZE® Technology Collaboration And License Agreement PR Newswire (US) - 5/22/2019 1:05:00 AM
Post-effective Amendment to an S-8 Filing (s-8 Pos) Edgar (US Regulatory) - 5/14/2019 5:11:52 PM
Post-effective Amendment to an S-8 Filing (s-8 Pos) Edgar (US Regulatory) - 5/14/2019 5:08:35 PM
Halozyme To Participate In Bank of America Merrill Lynch Health Care Conference 2019 PR Newswire (US) - 5/13/2019 8:01:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2019 4:14:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2019 4:07:11 PM
Halozyme Reports First Quarter 2019 Results PR Newswire (US) - 5/7/2019 4:01:00 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/6/2019 4:02:13 PM
Halozyme Names Dr. Alison A. Armour As Senior Vice President Of Research And Development PR Newswire (US) - 5/6/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/3/2019 5:08:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:30:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:26:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:23:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:21:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:18:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:14:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:11:43 PM
Halozyme To Host First Quarter 2019 Financial Results Webcast And Conference Call PR Newswire (US) - 4/23/2019 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/15/2019 4:09:46 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 3/22/2019 4:14:49 PM
Fred Kadiddlehopper   Wednesday, 05/08/19 09:57:38 AM
Re: None
Post # of 5630 
It sounds like they know that PEGpH20 is going to succeed.

Quote:
-------------------------------------------------------------------------------

James William Birchenough, Wells Fargo Securities, LLC, Research Division - MD and Senior Biotechnology Analyst [5]

--------------------------------------------------------------------------------

And then an important question we get is just what Halozyme might look like under different scenarios around HALO-301. And in one scenario, I think you've discussed you could be an ENHANZE-only company if the HALO-301 study doesn't go the way you think it'll go. Is that still the thought, and just trying to reconcile that with perhaps more focus on R&D recently.

--------------------------------------------------------------------------------

Helen I. Torley, Halozyme Therapeutics, Inc. - President, CEO & Director [6]

--------------------------------------------------------------------------------

We believe we've developed PEGPH20 in pancreas cancer that is significantly derisked it versus other pancreas cancer programs. And we are planning for success, and that is obviously why we are continuing to evaluate for future new indications to develop for PEGPH20 and brought in Alison. In the event we are surprised and PEGPH20 is not successful and we do not see a path forward for PEGPH20, we have said the most likely scenario is we would become an ENHANZE-only company. But we are planning for success.

--------------------------------------------------------------------------------



The more you know, the less you don't know.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist